Patients aged > or = 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy.
Journal Article (Letter)
Full Text
Duke Authors
Cited Authors
- Balducci, L; Lyman, GH
Published Date
- March 1, 2001
Published In
Volume / Issue
- 19 / 5
Start / End Page
- 1583 - 1585
PubMed ID
- 11230505
International Standard Serial Number (ISSN)
- 0732-183X
Digital Object Identifier (DOI)
- 10.1200/JCO.2001.19.5.1583
Language
- eng
Conference Location
- United States